Among the 46 breast cancers analyzed, TFF1 staining was graded as 3+ in 6 patients (13%), 2+ in 20 patients (43.5%), 1+ in 11 patients (23.9%), and no staining in 9 patients (19.6%). The gene discussed is TFF1; the disease is breast carcinoma.